Yazar "Deveci, Burak" için Bildiri Koleksiyonu listeleme
-
Glofitamab in relapsed/refractory diffuse large B cell lymphoma: Real world data
Ferhanoğlu, Burhan; Gülbaş, Zafer; Uzay, Ant; Özcan, Muhit; Özkalemkaş, Fahir; Dal, Mehmet Sinan; Kalyon, Hakan; Akay, Olga Meltem; Deveci, Burak; Bekoz, Hüseyin; Sevindik, Ömür Gökmen; Toptaş, Tayfur; Yılmaz, Asu Fergün; Koyun, Derya; Alkış, Nihan; Birtaş Ateşoğlu, Elif (American Society of Hematology, 2022)Abstract INTRODUCT ̇ION Glofitamab is a T-cell-engaging bispecific antibody connecting CD20 on B cells and CD3 on T cells. Although, most of the patients with B-cell non-Hodgkin lymphoma (BNHL) achieve complete response ... -
Ibrutinib as a promising treatment for pulmonary complications due to refractory chronic graft versus host disease
İlhan, Osman; Cengiz Seval, Güldane; Uzay, Ant; Kaya, Emin; Öztürk, Zübeyde Nur; Deveci, Burak; Yavaşoğlu, İrfan; Ural, Ali Uğur; Beköz, Hüseyin Saffet; Ayli, Meltem; Sevindik, Ömür Gökmen; Civriz Bozdağ, Sinem; Kurt Yüksel, Meltem; Gülbas, Zafer (Elsevier Science Inc, 2020)Introduction: Despite major improvements in allogeneic hematopoetic stem cell transplantation form matched related/ unrelated donor over last decades, chronic graft-versus-host disease (cGVHD) is still the leading cause ... -
A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib
İlhan, Osman; Cengiz Seval, Güldane; Civriz Bozdağ, Sinem; Deveci, Burak; Pehlivan, Mustafa; Kaynar, Leylagül; Yavaşoğlu, İrfan; Beköz, Hüseyin Saffet; Yönal Hindilerden, İpek; Yeğin, Zeynep Arzu; Dağdaş, Simten; Avşar, Ayşe; Özkan, Atilla Hasan; Fırat Tuğlular, Tülin; Göker, Hakan; Gülbaş, Zafer (Springer Nature, 2020)...